483
Samer Kazziha MDSamer Kazziha MD – FDA 483, Jul 31, 2020
Record Details
Samer Kazziha MD, a clinical investigator in Sterling Heights, MI, was cited for significant deficiencies related to an investigational trial. The inspection revealed failures in ensuring research participants received critical study updates and new risk information, as well as a failure to report a study hold to the Institutional Review Board (IRB). These issues indicate a lack of adherence to the investigational plan and IRB requirements.
View Company Profile
ID · d6ec4983-464a-4cab-9aa6-a3cfda6e6096
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.